Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large distant deletion disrupts CDKN2A enhancer and predisposes to melanoma.

medRxiv : the preprint server for health sciences·2026
Same author

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Federated Deep Learning Enables Cancer Subtyping by Proteomics.

Cancer discovery·2025
Same author

Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma.

JAMA dermatology·2025
Same author

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.

Cancer cell·2025
Same author

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

JCO precision oncology·2024

Related Experiment Video

Updated: May 26, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study.

Kirsten Howard1, Glenn P Salkeld, Graham J Mann

  • 1School of Public Health, University of Sydney, Sydney, New South Wales, Australia.

BMJ Open
|January 10, 2012
PubMed
Summary

Men

More Related Videos

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
07:14

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Related Experiment Videos

Last Updated: May 26, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
07:14

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Area of Science:

  • Urology
  • Public Health
  • Health Economics

Background:

  • Prostate cancer screening with prostate-specific antigen (PSA) testing is controversial.
  • Understanding men's willingness to accept benefit:harm trade-offs is crucial for informed screening decisions.
  • Limited data exists on patient preferences regarding PSA screening outcomes.

Purpose of the Study:

  • To investigate Australian men's preferences for prostate cancer screening via PSA testing.
  • To identify factors influencing men's decisions to participate in PSA screening.
  • To quantify the acceptable trade-offs between screening benefits and harms.

Main Methods:

  • Quantitative assessment of men's preferences for PSA screening using discrete choice methodology.
  • A web-based survey of approximately 1000 Australian men aged 40-69, stratified by prostate cancer family history.
  • Analysis using a mixed logit model to determine parameter estimates and odds of choosing screening.

Main Results:

  • The study quantifies men's preferences and trade-offs in prostate cancer screening decisions.
  • Identifies key factors influencing men's willingness to undergo PSA testing.
  • Provides data on acceptable benefit:harm ratios for screening.

Conclusions:

  • Findings will inform shared decision-making tools for prostate cancer screening.
  • Contributes to understanding patient values in the context of PSA testing.
  • Results will guide public health policy on prostate cancer screening programs.